Giulio Leone studies two main areas: sudden cardiac death in young individuals and the use of advanced language models to improve cancer data extraction in healthcare. In his research on sudden cardiac death, he investigates inherited heart conditions that often lead to these tragic outcomes. Leone emphasizes the importance of genetic testing and thorough autopsies to pinpoint causes, which can help identify risks for family members. In his work on cancer, he explores how to make data from electronic health records more reliable, especially for lung cancer. By combining expert insights with technology, he aims to enhance the accuracy of identifying cancer-related information, ultimately aiding doctors in making better treatment decisions.
Key findings
Genetic testing and thorough examinations can clarify causes of sudden cardiac death in the young, potentially leading to earlier detection for family members at risk.
General-purpose small language models identified cancer-related information in electronic health records with improved results when designed with expert input, achieving higher accuracy in complex tasks.
Effective data extraction from health records can significantly enhance treatment decision-making for lung cancer patients, as shown in the research utilizing data from the APOLLO 11 trial.
Frequently asked questions
Does Dr. Leone study sudden cardiac death?
Yes, Dr. Leone investigates the causes of sudden cardiac death in young people, focusing on inherited heart conditions.
What treatments has Dr. Leone researched?
While Dr. Leone's work primarily focuses on understanding issues and improving data systems, his findings aim to aid in early detection and treatment planning for heart conditions and cancer.
Is Dr. Leone's work relevant to families with a history of heart disease?
Absolutely, his research on sudden cardiac death can help families understand genetic risks and implement preventive measures.
How can Dr. Leone's work help cancer patients?
By improving the accuracy of cancer-related data in electronic health records, his research helps doctors make better treatment decisions for cancer patients.
What is the importance of genetic testing in Dr. Leone's research?
Genetic testing is crucial in identifying the specific causes of sudden cardiac death, potentially saving lives by informing family members of their risks.
Publications in plain English
[Proximal femoral resection with endoprosthetic reconstruction for malignant bone tumors : Surgical technique via the anterior hip approach].
2026
Orthopadie (Heidelberg, Germany)
Dammerer D, Ardelt M, Leone G, Thaler M, Putzer D +2 more
Plain English This study looked at a surgical method for removing tumors in the upper thigh bone (proximal femur) and replacing it with an artificial joint. The technique focuses on safely removing tumors while keeping nearby muscles and nerves intact to help patients regain hip stability. The researchers found that after this surgery, patients generally experienced good functional outcomes and low rates of complications, making it a reliable option for treating malignant bone tumors.
Who this helps: This research benefits patients with bone tumors in the upper thigh who need surgical intervention.
An Uncommon Localization of Hairy Cell Leukemia: Central Nervous System Involvement and Response to Ibrutinib-A Case Report and a Review of the Literature.
2026
American journal of hematology
Leone G, D'Antiga M, Pelloso M, Serafin A, Danesin N +9 more
Investigation of structural and thermal properties of solid lipid-based nanocarriers optimized by microfluidic synthesis.
2026
International journal of pharmaceutics
Gabbricci G, Talarico L, Clemente I, Sutinen A, Blanchet CE +3 more
Plain English This study looked at new types of drug delivery systems called lipid-based nanocarriers, which help protect and transport medicines in the body. Researchers created these nanocarriers using a method called microfluidic synthesis and found that by changing the ingredients and how they were mixed, they could significantly improve their stability and effectiveness. Specifically, they gained valuable insights into how the structure and properties of these carriers relate to their ability to deliver drugs efficiently.
Who this helps: This benefits patients by potentially providing more effective treatments with fewer side effects.
Iron Therapy in Pediatric Iron Deficiency and Iron-Deficiency Anemia: Efficacy, Safety, and Formulation-Specific Trade-Offs-A Narrative Review.
2026
Hematology reports
Leone G, Arrabito M, Russo G, La Spina M
Plain English This study looked at different treatments for children with iron deficiency and iron-deficiency anemia, which are common conditions that can affect a child's growth and health. It found that while traditional iron pills (ferrous salts) are effective, up to 40% of kids have stomach problems with them, so a lower dose or taking them every other day can help. Newer iron formulations are also better tolerated and work well, especially for kids who have trouble absorbing iron or have other health issues.
Who this helps: This helps children with iron deficiency, their parents, and healthcare providers.
Balancing safety and efficacy of Bendamustine plus anti CD20 regimens in elderly patients (> 70 y) with follicular lymphoma: a tertiary academic center experience.
2026
Annals of hematology
D'Antiga M, Danesin N, Leone G, Carraro M, Scapinello G +6 more
Plain English This study looked at how well the cancer treatment Bendamustine combined with other drugs works and its safety for elderly patients (over 70 years) with follicular lymphoma. Among 39 patients reviewed, those receiving lower doses of Bendamustine had a median overall survival of 31.5 months, while those getting full doses had 65 months, but the difference wasn't statistically significant. Importantly, reducing the dose didn't lead to more side effects, which indicates that it's safe for older patients to get lower doses without significantly hurting their chances of recovery.
Who this helps: This helps elderly patients with follicular lymphoma and their doctors by providing insight into safer treatment options.
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases.
2026
Nature medicine
Becilli M, Metzler M, Bracaglia C, Nicolai R, Krickau T +28 more
Plain English This study looked at a new treatment for eight children with severe autoimmune diseases that did not respond to traditional therapies. After receiving a special type of immune cell therapy called anti-CD19 CAR T cells, all children showed significant improvements over about 16.5 months, with no severe infections and manageable side effects. This is important because it suggests that this treatment could offer a new hope for pediatric patients suffering from difficult-to-treat autoimmune diseases.
Who this helps: Patients with severe autoimmune diseases who have not responded to other treatments.
Plastic clean-up mechanisms: Experimental insights on their bycatch.
2026
Marine pollution bulletin
Leone G, Catarino AI, Pauwels I, Bossaer M, Oco RC +4 more
Plain English This research studied how effective different plastic clean-up devices are at removing plastic waste from water without harming other materials and organisms in the environment. The findings revealed that two tested clean-up methods picked up a lot of unintended sea plants and other organic materials alongside the plastic, with bycatch rates ranging from about 18% to as high as 95%. This is important because high bycatch can disrupt ecosystems, so understanding these rates helps improve cleanup methods to protect the environment while removing plastic.
Who this helps: This helps environmental advocates and policymakers working to protect aquatic ecosystems.
EZH2 Inhibition Reshapes 3D Chromatin Architecture to Induce Immunogenic Phenotype in Small Cell Lung Cancer.
2026
bioRxiv : the preprint server for biology
Parveen S, Adhinaveni R, Fang K, Choppavarapu L, Du M +4 more
Plain English This study looked at how blocking the EZH2 protein affects the structure of DNA in small cell lung cancer (SCLC) cells and how this might improve responses to treatments. Researchers found that using an EZH2 inhibitor called Valemetostat changed the arrangement of DNA in ways that made cancer cells more responsive to immune therapy; specifically, it increased the expression of important genes related to the immune response without harming the cells. This is important because enhancing the immune system's ability to target cancer can lead to better treatment outcomes for patients.
Who this helps: Patients with small cell lung cancer.
Prognosis and Treatment Response in Aggressive-variant Prostate Cancer and Treatment-related Neuroendocrine Prostate Cancer: A Systematic Review and Meta-analysis.
2026
European urology oncology
Pedrani M, Salfi G, Pecoraro G, Puglisi M, Turco F +15 more
Plain English This study focused on different types of aggressive prostate cancer and how they respond to treatments. Researchers analyzed 40 studies and found that aggressive prostate cancer is linked to shorter survival times, with patients having about 2.72 times higher risk of disease progression compared to non-aggressive types. Platinum-based chemotherapy was significantly more effective, showing a response rate of 46% compared to 19% for other treatments and offering better survival outcomes for patients with aggressive forms.
Who this helps: This helps patients with aggressive prostate cancer by providing insights into more effective treatment options.
Examining External Load Variability in a Cadet Population: Impact on Vertical Jump Performance.
2026
Military medicine
Beach TJ, Fraley AL, Sole CJ, Leone GE, Waddy DC +1 more
Plain English This study looked at how carrying extra weight affects the jumping ability of military cadets. Researchers found that when cadets carried 22% of their body weight, their jump height dropped significantly—females jumped an average of 21.6 cm and males 34.8 cm without added weight, but performance decreased when they carried the extra load. This is important because it shows that even a small amount of added weight can negatively impact physical performance, which has implications for training and readiness in military settings.
Who this helps: This helps military trainers and cadets in understanding how to manage physical loads during training.
Exposome Risk Factors for Vitiligo: A Systematic Evidence Review.
2026
American journal of clinical dermatology
Piquero-Casals J, Bertold C, Alomar A, Morgado-Carrasco D, Gilaberte Y +8 more
Plain English This study examined how different environmental factors, or the "exposome," influence the onset and progression of vitiligo, a skin disorder. Researchers found that certain drugs, especially immune checkpoint inhibitors used for melanoma, can cause vitiligo in 7-25% of patients. Other factors like exposure to phenol chemicals, COVID-19 infection (which increased risk slightly), and lifestyle choices like stress and smoking were also linked to the condition but with less certainty. Understanding these triggers is crucial because it can help identify at-risk individuals and guide prevention strategies.
Who this helps: This information is beneficial for patients with vitiligo, healthcare providers, and researchers studying autoimmune conditions.
Forensic pathological and genetic landmarks in sudden cardiac death in the young: An update.
2026
Forensic science international. Genetics
Grassi S, Campuzano O, Ferri E, Leone G, Rossi R +7 more
Plain English This study looked at sudden cardiac death in young people, which is often caused by inherited heart conditions. Researchers found that thorough examinations and genetic testing can help determine the exact cause of these deaths, since many autopsies yield unclear results. Understanding the genetic factors involved is crucial for identifying family members who may be at risk and for implementing preventive measures.
Who this helps: This benefits patients, their families, and doctors by improving early detection and prevention of heart-related issues.
Knee kinematics during gait in patients with discoid lateral meniscus: a systematic review.
2025
Minerva pediatrics
Turati M, Anghilieri FM, Daniel O, Piatti M, Leone G +7 more
Plain English This study looked at how people with a condition called discoid lateral meniscus (DLM) walk compared to healthy individuals. Researchers found that those with DLM had slower walking speeds and shorter steps, as well as less movement in their knees during walking. After surgery, some patients did see improvements, with one study noting increased walking speed and better knee movement.
Who this helps: This research benefits patients with discoid lateral meniscus by showing potential improvement after surgery.
Maternal Phenylketonuria and Offspring Outcome: A Retrospective Study with a Systematic Review of the Literature.
2025
Nutrients
Leone G, Meli C, Falsaperla R, Gullo F, Licciardello L +11 more
Plain English This study looked at the effects of phenylketonuria (PKU) on pregnancies in women with this condition. It found that women who started a strict diet before getting pregnant and kept their phenylalanine levels in check had much better outcomes for their babies, including lower rates of heart defects and growth problems. Specifically, the study showed that these women had a miscarriage rate of just 0.14%, while those who didn't manage their diet well faced higher risks of serious issues like congenital heart disease and intellectual disabilities.
Who this helps: This helps women with PKU and their healthcare providers.
Real-Time sEMG Processing With Spiking Neural Networks on a Low-Power 5K-LUT FPGA.
2025
IEEE transactions on biomedical circuits and systems
Scrugli MA, Leone G, Busia P, Raffo L, Meloni P
Plain English This study focused on improving how we read electrical signals from muscles in the hand (called sEMG signals) to create better prosthetic devices and robotic systems that can mimic human movements. The researchers developed a method using lightweight neural networks that achieved an accuracy of 83.17% in recognizing different finger gestures and was able to closely model finger force during exercises, with a high correlation of up to 0.875 to actual force measurements. This technology is important as it allows for smoother and more precise control of prosthetics, making them more functional and user-friendly.
Who this helps: This helps patients needing prosthetic limbs and those reliant on assistive devices.
Mismatch Between Preoperative MRI Findings and Postoperative Histological Results in the Treatment of Tenosynovial Giant Cell Tumor.
2025
Anticancer research
Neugebauer J, Blum P, Keiler A, SÜß M, Reinbacher P +4 more
Plain English This study looked at how accurately pre-surgery MRI scans matched up with the actual findings after surgery in patients with tenosynovial giant cell tumors (TGCT), a rare type of tumor common in young adults. Out of 137 patients, 52 were analyzed, and the results showed that in 37 patients (71%), the MRI results were correct, while 15 patients (29%) had false-positive MRI results indicating TGCT when the tumor was not present. This gap between imaging and actual findings matters because it highlights the need for more accurate diagnosis methods, such as preoperative biopsies, to avoid unnecessary surgeries.
Who this helps: Patients with TGCT and their doctors.
Photoprotection in pregnancy: addressing safety concerns and optimizing skin health.
2025
Frontiers in medicine
Lim HW, Piquero-Casals J, Schalka S, Leone G, Trullàs C +5 more
Plain English This study looked at how pregnant women can protect their skin from the sun, especially since pregnancy can cause changes that lead to skin issues like dark patches. It found that using broad-spectrum sunscreens can significantly help prevent these problems, but many pregnant women do not use them. The review recommends mineral-based, tinted sunscreens that match different skin tones as a good option to protect against skin damage and improve appearance, along with wearing sun-safe clothing and hats.
Who this helps: This helps pregnant women seeking to protect their skin health and appearance.
Current Concepts in the Management and Treatment of Spinal Metastases-A Systematic Literature Review.
2025
Cancers
Palacio Giraldo A, Dammerer V, Neugebauer J, Leone G, Schindler M +1 more
Plain English This study reviewed recent research on how to effectively manage spinal metastases, which are cancer spreads to the spine that can lead to serious health issues. It highlighted the need for personalized treatment plans and emphasized the importance of using specific guidelines to assess symptoms and make treatment decisions. The review found that a multidisciplinary approach and early diagnosis greatly improve patient outcomes, but more research is needed to enhance treatment strategies.
Who this helps: This helps patients with spinal metastases and their healthcare teams.
DNA replication in primary hepatocytes without the six-subunit ORC.
2025
eLife
Przanowska RK, Chen Y, Uchida TO, Shibata E, Hao X +7 more
Plain English This study looked at a group of proteins called ORCs that are important for starting the process of DNA replication in cells. Researchers found that mouse liver cells can replicate their DNA even when a key protein, ORC2, is removed, which is different from other types of cells that can't do this without ORC2. These findings are significant because they show that liver cells can replicate DNA without relying on ORC, similar to cancer cells, which could lead to new treatments or insights into liver function and cancer biology.
Who this helps: This helps researchers and doctors studying liver diseases and cancer.
The Effects of a Multidisciplinary Residential Program on the Risk Factors of Sarcopenic Obesity: An Open-Label Trial Study in a Cohort of Institutionalized Italian Adults with Obesity.
2025
Nutrients
Rondanelli M, Gasparri C, Moroni A, Genovese E, Valentini EM +3 more
Plain English This study investigated how a 2-month program combining personalized nutrition, exercise, and psychological support can help older adults in Italy who have obesity and are at risk for sarcopenic obesity, a condition with too much fat and not enough muscle. After participating in the program, the 61 adults showed significant improvements: they lost an average of 6.4 kg, their physical performance scores increased by nearly 1 point, and their blood sugar and cholesterol levels also improved substantially. This is important because it shows that a structured program can enhance health and mobility in people who are often overlooked in traditional obesity treatments.
Who this helps: This helps older adults with obesity and healthcare providers working to improve their health.
Extracorporeal Blood Purification Therapy to Deal a Deferasirox Induced Life-Threatening Hepatic Encephalopathy in a Septic Child With Sickle-Cell Disease: A Case Report.
2025
Journal of clinical apheresis
Rossetti E, Cappoli A, Labbadia R, Leone G, Chiusolo F +3 more
Plain English This case report discusses a 15-year-old girl with sickle-cell disease who developed severe brain swelling after taking a medication called deferasirox, intended for iron removal. She experienced significant symptoms including confusion and seizures, and her tests showed dangerously high ammonia levels and signs of organ failure. After stopping the medication and providing specialized treatments, including a type of blood purification, she recovered without lasting effects.
Who this helps: This helps patients with chronic diseases like sickle-cell, their families, and their doctors by highlighting the risks of certain medications and the need for quick action in emergencies.
Wearable Epilepsy Seizure Detection on FPGA With Spiking Neural Networks.
2025
IEEE transactions on biomedical circuits and systems
Busia P, Leone G, Matticola A, Raffo L, Meloni P
Plain English Researchers developed a lightweight, wearable device that can accurately detect seizures using a special type of artificial intelligence called Spiking Neural Networks (SNNs). Their system achieved an impressive 99.3% accuracy in identifying seizures, detected all the seizures tested, and only made 0.3 false alarms per hour. This matters because it provides a reliable way for people with epilepsy to get real-time monitoring without being cumbersome, making it easier to manage their condition.
Who this helps: This helps patients with epilepsy and their caregivers.
Distinct viral reservoirs and immune signatures in individuals on long-term antiretroviral therapy with perinatally acquired HIV-1.
2025
Cell reports. Medicine
Bone B, Cotugno N, Pighi C, Rotili A, Hong S +26 more
Plain English This study looked at nine young adults who were diagnosed with HIV-1 at birth and have been on treatment since they were infants. The researchers found that these individuals had much smaller viral reservoirs—meaning fewer traces of the virus—in their blood compared to older adults who started treatment later. They also had more immune cells capable of fighting the virus, which suggests that starting treatment early in life allows for a stronger immune response against HIV-1.
Who this helps: This benefits patients with perinatally acquired HIV-1, particularly those who start treatment early in life.
Positioning, navigation, and timing on the Moon and Mars with galactic cosmic rays.
2025
iScience
Leone G, Tanaka HKM, Holma M, Krishnan S, Duffy AR +10 more
Plain English This research studied a new technology called the muometric wireless navigation system (MuWNS) that uses particles called muons to transmit signals underground, even in places where traditional signals can't reach, like on the Moon and Mars. The system can send signals through about 1.5 to 2 kilometers of rock on Earth and can help identify suitable locations for underground bases, as well as potential resources like water ice or valuable minerals. This is important for future space exploration and establishing human bases on other planets.
Who this helps: This helps astronauts and scientists planning missions to the Moon and Mars.
Bioresponsive Hyaluronic Acid-Based Hydrogel Inhibits Matrix Metalloproteinase-2 in Glioblastoma Microenvironment.
2025
ChemMedChem
Barbugian F, Salerno D, Ballarini E, Crippa L, Francesconi O +9 more
Plain English Researchers studied a special gel made from hyaluronic acid that can help treat glioblastoma, a very aggressive brain cancer. This gel not only fills in the gaps left after surgery but also releases a substance that blocks a specific protein (MMP-2) known to help tumors grow and spread. The gel is designed to be effective specifically in the environment around the glioblastoma, which is crucial for improving treatment outcomes for patients.
Who this helps: Patients with glioblastoma.
Point-of-care fresh CAR T cells for pediatric or young adult BCP-ALL that is relapsed/refractory or in very-high-risk first relapse.
2025
Blood advances
Del Bufalo F, Becilli M, Rosignoli C, Merli P, Algeri M +16 more
Plain English Researchers studied a new method for making CAR T cells directly at the treatment site for children and young adults with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) who have relapsed or are at very high risk of relapse. They found that 68% of the 19 patients treated achieved complete remission, and 83% were alive three years later. This approach makes CAR T cell therapy more accessible and efficient, which is crucial for improving outcomes in this high-risk patient group.
Who this helps: This helps pediatric and young adult cancer patients facing difficult-to-treat leukemia.
TCF3 and ID3 Regulate TSPAN32 Expression in Burkitt Lymphoma.
2025
Scandinavian journal of immunology
Scuderi G, Mangano K, Leone GM, Fagone P, Nicoletti F
Plain English This study looked at how the TSPAN32 gene is controlled in different types of Burkitt lymphoma, a severe form of cancer affecting B-cells. Researchers found that TSPAN32 levels were significantly lower in all studied types of Burkitt lymphoma, regardless of whether the cells were infected with the Epstein-Barr virus. They discovered that certain genes, TCF3 and ID3, play crucial roles in regulating TSPAN32 levels, which could help in developing new treatments or tests for the disease.
Who this helps: This benefits patients with Burkitt lymphoma and their doctors.
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study.
2025
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Leone G, Wong YNS, Jones RJ, Sankey P, Josephs DH +23 more
Plain English The NEPTUNES study tested a combination of two immunotherapy drugs, nivolumab and ipilimumab, in patients with advanced prostate cancer that had specific features making it likely to respond to this type of treatment. Out of 71 patients, 32% showed a positive response to the treatment, with the best results seen in those who had specific genetic changes or high levels of inflammation in their tumors. This research is important because it highlights a potentially effective treatment option for a challenging type of cancer and suggests that certain genetic features can help identify which patients are most likely to benefit.
Who this helps: This helps patients with advanced prostate cancer who have specific genetic traits that make their cancer immunogenic.
Added Value of SPECT/CT in Radio-Guided Occult Localization (ROLL) of Non-Palpable Pulmonary Nodules Treated with Uniportal Video-Assisted Thoracoscopy.
2025
Journal of clinical medicine
Aricò D, Motta L, Giacoppo G, Bambaci M, Macrì P +10 more
Plain English This study looked at improving the method used to locate small lung nodules that can't be felt (non-palpable) before surgery. Researchers found that using a special imaging technique called SPECT/CT helped accurately identify the location of these nodules in a lot of cases—91% showed better results compared to the standard method. Even though the surgery time increased slightly to an average of 39 minutes and there were more cases of pneumothorax (43% with SPECT/CT vs. 1.6% without), the high success rate of 96% in finding the nodules is significant for any complicated cases.
Who this helps: This benefits patients with difficult-to-locate lung nodules.
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial.
2025
Nature medicine
Locatelli F, Pagliara D, De Ioris MA, Becilli M, Del Baldo G +23 more
Plain English This study looked at a new treatment using GD2-targeting CAR T cells, known as GD2-CART01, for children with high-risk neuroblastoma who have not responded to other treatments. Out of 35 patients, about 66% showed a positive response, with 37% achieving complete remission within six weeks. After about four years, 43% of the patients were still alive, which is significant for this tough-to-treat cancer.
Who this helps: This benefits children with high-risk neuroblastoma and their families.
Fatty Acid Profiling of Breast Milk at Different Gestational Ages.
2025
Nutrients
De Bernardo G, Leone G, Izzo F, Giovengo M, Basilicata MG +9 more
Plain English This study looked at the types of fatty acids in breast milk for mothers who gave birth at different times: around 32 weeks, between 32-36.6 weeks, and after 37 weeks. Researchers found that while the overall fat content in breast milk remained similar, certain fatty acids changed significantly, especially at 7 days after birth, with specific dietary habits influencing these fats. For instance, eating fish was linked to beneficial fatty acids like DHA and EPA, which are important for brain development, especially for preterm infants.
Who this helps: This benefits mothers and healthcare providers caring for newborns, especially those born prematurely.
Synthesis and in vitro evaluation of polyethylene glycol-treprostinil conjugates for sustained local delivery in pulmonary arterial hypertension.
2025
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Leone G, Ucakar B, Perros F, Frédérick R, Vanbever R
Plain English This research focused on improving the way treprostinil, a drug used to treat pulmonary arterial hypertension (PAH), is delivered to patients. The scientists created a new form of treprostinil combined with polyethylene glycol that allows for slower release of the drug in the lungs, which could mean fewer doses are needed. They found that certain modifications to the drug's structure slowed down its release in lab tests, indicating a potential for more effective treatment over time.
Who this helps: This benefits patients with pulmonary arterial hypertension who need more reliable and sustained medication delivery.
Predictive Factors of Suboptimal Response to Topical 0.1% Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: A Real-World Retrospective Study.
2025
Ophthalmology and therapy
Nassisi M, Osnaghi S, Leone G, Mapelli C, Altavilla C +3 more
Plain English This study looked at how well a treatment called 0.1% cyclosporine A cationic emulsion works for children with severe forms of a condition called vernal keratoconjunctivitis (VKC). Out of 101 children studied, 17.8% needed stronger treatments after using this medication for about 1.4 years. The researchers found that a specific scoring system to measure disease severity can predict who might not respond well to this treatment, indicating that early changes in therapy might be needed for those with higher scores.
Who this helps: This helps pediatric patients with VKC and their doctors in managing their treatment more effectively.
Toward assessing serodiagnosis of Q fever in high occupational-risk workers.
2025
Comparative immunology, microbiology and infectious diseases
Morea A, Trerotoli P, Stufano A, Schino V, Di Leone G +10 more
Plain English This study looked at how well different blood tests can diagnose Q fever, a disease that can affect people working in high-risk jobs. Among 269 workers tested, 55% had antibodies indicating they were exposed to the bacteria that cause Q fever, with specific indicators suggesting possible chronic or acute cases. The study found that while one test (ELISA) was very good at identifying those who were infected, it also had higher chances of giving false positives, meaning confirmatory tests are still needed.
Who this helps: This research benefits high-risk workers and healthcare providers managing their health.
Assessment of vitiligo in clinical practice: a cross-sectional survey among experts.
2025
The Journal of dermatological treatment
Duponselle J, Jukema MR, Wolkerstorfer A, Ezzedine K, Hamzavi I +29 more
Plain English This study looked at how vitiligo experts currently evaluate patients with the skin condition vitiligo. Researchers surveyed 31 experts worldwide and found that they commonly assessed six key outcomes, including how the disease changes over time and the side effects of treatments, while 21 additional characteristics were also noted. This knowledge is important because it helps create a standard way to measure vitiligo in clinical practice, which can lead to better care for patients.
Who this helps: This benefits patients with vitiligo and their doctors.
Comonomer Discrimination in Copolymerization of β‑Myrcene: Ethylene Inhibition, Spectators, and Soft Elastomers with Isoprene.
2025
ACS polymers Au
Grieco S, Di Girolamo R, Ritacco I, Falivene L, Leone G
Plain English This study focused on creating soft, flexible materials called elastomers from a natural source, β-myrcene, mixed with other substances. Researchers found that when β-myrcene is combined with isoprene, it produces high-quality elastomers that can be easily adjusted for different uses, with a strong ability to form stable films. These materials are important because they can reduce our reliance on non-renewable resources and help develop more environmentally friendly products.
Who this helps: This benefits manufacturers and industries looking for sustainable materials, as well as patients who rely on medical devices made from these materials.
PINGing Sunshine: A Review of the Evidence for Adding Non-Filtering Photoprotective Ingredients to Sunscreens.
2025
Photodermatology, photoimmunology & photomedicine
Krutmann J, Brown A, Passeron T, Granger C, Gilaberte Y +5 more
Plain English This study looked at special ingredients called non-filtering photoprotective ingredients (PINGs) that can boost the skin's defenses against sun damage when added to sunscreens. Researchers found that some top ingredients, like L-ascorbic acid and tocopherol, significantly improved protection against skin issues caused by the sun, such as burns and aging. Only a small number of these ingredients have been tested for safety and effectiveness in sunscreens, suggesting that more research is needed to make better sun protection options available.
Who this helps: This helps patients seeking better sun protection and dermatologists looking for effective treatments.
Transcriptomic and Clinical Profiling Revealsas a Prognostic Oncogene in Pancreatic Cancer.
2025
Genes
Scuderi G, Mijatovic S, Maksimovic-Ivanic D, Di Rosa M, Muñoz-Valle JF +5 more
Plain English This study looked at a protein called Galectin-3 (Gal-3) and its role in pancreatic cancer and other cancer types. Researchers found that high levels of Gal-3 are linked to worse survival rates in patients with several cancers, including pancreatic ductal adenocarcinoma (PDAC), where increased Gal-3 levels were associated with poorer outcomes. Specifically, they noted that Gal-3 expression correlates with overall survival rates, highlighting its potential as a target for future treatments.
Who this helps: This helps patients with pancreatic cancer and other malignancies by providing insights into new treatment options.
Plasma Cell Leukemia Update on Immunophenotype, Molecular Characteristics, and Therapy. The Second Part of Plasma Cell Neoplasms with Spreading in the Blood and Tissues.
2025
Mediterranean journal of hematology and infectious diseases
Leone G, Testa U
Plain English This study focuses on plasma cell leukemia (PCL), a rare and aggressive form of multiple myeloma. It was found that PCL occurs in 2-4% of newly diagnosed multiple myeloma cases and is more severe, often leading to kidney failure and elevated tumor markers. Treatment for PCL is similar to other myeloma types, but outcomes are not as promising.
Who this helps: This research helps patients with plasma cell leukemia and their doctors by improving understanding and treatment strategies.
Perioperative Patient Blood Management in Primary Knee and Hip Arthroplasty-Nonsense or Necessity?
2025
Journal of clinical medicine
Neugebauer J, Strassegger C, Putzer D, Schindler M, Palacio-Giraldo A +4 more
Plain English This study looked at how well blood is managed for patients before, during, and after knee and hip surgeries, focusing on the issues of anemia (low red blood cell count). The researchers found that 5% of the 801 patients needed blood transfusions, with 8% of those undergoing hip replacements needing transfusions compared to only 2% for knee replacements. This highlights the need for better blood management practices to minimize the need for transfusions and improve patient outcomes.
Who this helps: This helps patients undergoing knee and hip surgeries.
Directions of Immunotherapy for Non-Small-Cell Lung Cancer Treatment: Past, Present and Possible Future.
2025
International journal of molecular sciences
Leone GM, Scuderi G, Fagone P, Mangano K
Plain English This research looked at how immunotherapy is changing the treatment of non-small-cell lung cancer (NSCLC), which makes up 85% of lung cancer cases. Researchers highlighted recent advancements, including new immune checkpoint inhibitors that have improved outcomes for many patients, while also discussing both the benefits and limitations of these treatments. The goal is to customize treatments based on individual patient characteristics, which could lead to more effective care.
Who this helps: This helps patients with non-small-cell lung cancer and their doctors.
Extent of bone marrow infiltration predicts disease progression in asymptomatic Waldenström macroglobulinemia.
2025
Discover oncology
Danesin N, Leone G, D'Antiga M, Scapinello G, Carraro M +10 more
Plain English This study looked at how the amount of cancer found in the bone marrow affects the progression of asymptomatic Waldenström macroglobulinemia (WM). Researchers classified 150 patients into two groups based on whether 25% or more of their bone marrow was affected. They found that those with higher bone marrow tumor burden had a much shorter time to progression—64 months compared to 137 months for those with lower burden—and that elevated levels of a specific protein (IgM) were linked to faster progression of the disease.
Who this helps: This information benefits doctors and patients by helping to predict disease progression in those with asymptomatic WM.
Plain English This study looked at how a specific genetic change in mice affects the connection between the placenta and fetal brain, particularly focusing on serotonin's role in that process. Researchers found fewer important cells in the placenta of genetically altered mice, which may disrupt brain development, especially in female fetuses, although the overall serotonin levels were similar between groups. These findings are important because they could help understand potential risks for pregnant women taking antidepressants, which may affect their baby's development.
Who this helps: This helps pregnant women and their healthcare providers.
Prognostic and predictive impact of NOTCH1 mutations in patients with chronic lymphocytic leukemia: a tertiary single-center experience.
2025
Frontiers in oncology
D'Antiga M, Serafin A, Angotzi F, Cellini A, Bevilacqua A +8 more
Plain English This study examined the impact of NOTCH1 mutations in 271 patients with chronic lymphocytic leukemia (CLL) treated at a medical center from 1999 to 2023. It found that 14% of these patients had NOTCH1 mutations, leading to worse overall survival (244 months compared to 293 months for patients without the mutations). The research highlights the need for routine testing of NOTCH1 mutations, as it can help doctors better assess risks and tailor treatments for CLL patients.
Who this helps: This benefits CLL patients and their doctors by improving risk assessment and treatment options.
Combining Clinician Expertise with Prompt Engineering enhances Small Language Models Reliability for Cancer Entity Recognition in Electronic Health Records.
2025
medRxiv : the preprint server for health sciences
Corso F, Peppoloni V, Mazzeo L, Leone G, Passos L +39 more
Plain English This study looked at how well small language models can identify cancer-related information in electronic health records (EHRs), specifically focusing on lung cancer data from the APOLLO 11 trial. Researchers tested different ways to design prompts for these models and found that general-purpose models performed better, especially in simpler tasks, while using expert input improved the accuracy of more complex data. This matters because effective extraction of cancer data can help doctors make better decisions and improve patient outcomes by using real-world information securely and accurately.
Who this helps: Patients and healthcare providers who rely on accurate cancer data for treatment decisions.
Giovanni Leone Henry W Lim Thierry Passeron Jaime Piquero-Casals Yolanda Gilaberte Jean Krutmann Giovanna Leone Marco Becilli Francesca Del Bufalo Chiara Rosignoli
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.